Petros pharmaceuticals partners with blockbuster cholesterol drug(1) crestor's (rosuvastatin) otc switch technology provider

Idea evolver is the only provider to successfully complete actual use trial for fda review for rx-to-otc switch approval new york, ny / accesswire / december 5, 2023 / petros pharmaceuticals, inc. (nasdaq:ptpi), a company focused on expanding consumer access to medication through over-the- counter (otc) drug development programs, announces its partnership with idea evolver (ie), a technology platform for rx-to-otc switches and digital pharmaceutical launch solutions. the partnership will focus on developing an application to help facilitate the technology element for the company's prescription to otc switch for its erectile dysfunction drug stendra® (avanafil).
PTPI Ratings Summary
PTPI Quant Ranking